These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 15781862)

  • 1. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.
    Song H; Wang R; Wang S; Lin J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4700-5. PubMed ID: 15781862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.
    Turkson J; Ryan D; Kim JS; Zhang Y; Chen Z; Haura E; Laudano A; Sebti S; Hamilton AD; Jove R
    J Biol Chem; 2001 Nov; 276(48):45443-55. PubMed ID: 11579100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
    Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
    Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.
    Turkson J; Kim JS; Zhang S; Yuan J; Huang M; Glenn M; Haura E; Sebti S; Hamilton AD; Jove R
    Mol Cancer Ther; 2004 Mar; 3(3):261-9. PubMed ID: 15026546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
    Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
    Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potential Stat3-regulated genes in human breast cancer.
    Hsieh FC; Cheng G; Lin J
    Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
    Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
    Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
    Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J; Jove R
    Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
    Turkson J; Bowman T; Garcia R; Caldenhoven E; De Groot RP; Jove R
    Mol Cell Biol; 1998 May; 18(5):2545-52. PubMed ID: 9566874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
    Nam S; Buettner R; Turkson J; Kim D; Cheng JQ; Muehlbeyer S; Hippe F; Vatter S; Merz KH; Eisenbrand G; Jove R
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5998-6003. PubMed ID: 15837920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
    Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
    Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.
    Turkson J; Zhang S; Palmer J; Kay H; Stanko J; Mora LB; Sebti S; Yu H; Jove R
    Mol Cancer Ther; 2004 Dec; 3(12):1533-42. PubMed ID: 15634646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.